Introduction
Annually, around 13 000 children in the world are diagnosed with acute lymphoblastic leukemia. White children are more frequently affected than black children, and there is a slight male preponderance. With improvements in diagnosis and treatment, the overall cure rates for children with acute lymphoblastic leukemia have reached 90 % (25) .
the two most important factors reported to be predictive of greater risk of relapse are age and white blood cell count (WBc) at diagnosis (22, 25) . investigators from the Berlin-Frankfurt-Munster (BFM) cooperative clinical trials consortium incorporate peripheral blast count and liver and spleen size into a single variable that can be used in risk-based classification (8) . The National Cancer Institute (NCI)/Rome criteria stratify patients into subsets based on age 1 to 9.99 years and WBC < 50 000/μL (standard risk), or age ≥ 10 years and/or WBC ≥ 50 000/μL (higher risk) (22, 25) . These variables have consistently emerged as independent predictors of outcome in almost all therapeutic studies. the obvious advantage of this system is that these variables can be measured reliably in almost all circumstances, and therefore these criteria can be applied to children worldwide (8) .
the purpose of this article is to prospectively determine the prognostic significance of the marker TEL-AML1 in Bulgarian children with acute lymphoblastic leukemia, to estimate event (relapse and death) survival time. clinical prognostic risk factors as age, gender, white blood cell count at diagnosis, risktype group are taken as predictors (covariates) of multivariate analysis by using cox proportional hazards regression. the comparison of the survival characteristics between two groups of patients: with tel-AMl1 and without this marker using the Kaplan-Meier estimator and cox model is made. the software package StAtiSticA 10.0 is used (23) .
Patients and Measurements
the data were collected in the Specialized children's Oncohematology Hospital -Sofia, Bulgaria. In this paper we describe the models using a cancer survival data set on 160 individuals from two groups: with Marker tel-AMl1 (33 patients) and without this marker (127 patients). the explanatory variables (covariates) are:
• Sex -takes the values "1" for male or "0" for female;
• Risk Group -coded : "0" for standard risk, "1" for medium risk, and "2" for higher risk;
• AGE in years;
• WBC -white blood cell count at diagnosis [number/ μL];
• M_Event -the survival time (in months);
• M_Lethal -the survival time (in months) for death;
• Event and Lethal -coded by "1" if event(s) happened or "0" if no event at the end of the study, i.e. "right censored";
• Marker -coded by "1" if the patient has tel-AMl1 and "0" if not.
The data for the first six individuals from the group without marker tel-AMl1 are shown in Table 1 . For example, subject 1 in this table died after 9 months of follow-up, whereas subject 4 was still alive after 41 months of follow-up.
For the group without marker tel-AMl1 the minimal value of the variable AGe was 3 months (0.25 years) and the maximum was 18 years, the median of AGe was 7 years; 62.2 % of the studied patients were male; 78.74 % of the patients had no marker at all; a relapse occurred for 25.98 % of the patients; the mean value for M_event was 37 months, and the mean for M_lethal was 37.4 months. the minimum value of leukocytes was 0.5 (10 9 )/l. the censored cases for relapse were 75.21 %, and for death, 71.65 %.
For the group with marker tel-AMl1 the minimal value of the variable AGe was 2 years and the maximum was 16 years, the median of the variable AGe was 4 years; 60.6 % of the patients were male; a relapse occurred for 6.06 % of the patients; the mean for M_event was 37.70 months and the mean for M_lethal was 37.67 months. the censored cases for events were 93.75 %, and for death 90.91 %.
Background of the statistical methods
one of the oldest and most straightforward methods for analyzing survival data is the life table technique, which was proposed by Berkson and Gage (2) for studying cancer survival. this method uses an enhanced frequency distribution approach. As reviewed by Ahmed et al. (1) , while the life table method has been shown to work well for a homogeneous sample, it does not address a primary goal of cancer research, namely to determine whether or not certain continuous and/or categorical variables are related to the survival times (1) . this need led to the application of regression methods for analyzing survival data. the standard multiple linear regression model is not well suited to survival data. two important developments that have greatly enhanced survival analysis methods are the derivation of a nonparametric method for constructing a survival curve from censored data by Kaplan and Meier (12) , and the Proportional hazards model proposed by cox (1, 4, 5) . the cox model, a multivariate semi-parametric regression model, is the most widely used in clinical studies to characterize disease progression on existing cases by revealing the importance of covariates . it is the most popular model for survival analysis due to its simplicity (1).
Proportional Hazards Model let T represent survival time.
T is regarded as a random variable with cumulative distribution function ( ) ( ) P t P T t = ≤ and probability density function
A fourth representation of the distribution of survival times is the hazard function, which assesses the instantaneous risk of demise at time t, conditional on survival to that time (9, 10) :
P t T t t T t h t t
the hazard is sometimes referred to as the "force of mortality" or the "conditional failure rate" (1) .
Survival analysis typically estimates the relationship of the survival distributions to covariates. Most commonly, this estimation entails the specification of a linear-like model for the log hazard (9) . A parametric model based on the exponential distribution may be written as 1 1 log ( ) ... . thus, the hazard ratio-HR (also called relative risk -RR) for two individuals with covariates X and X* does not depend on time, which gives the reason for the name "Proportional hazards Model" (1):
it is also noteworthy that the effects of the covariates on the hazard are assumed to be constant over time. inference 
Kaplan-Meier estimator of survival function
For real data the survival function ( ) S t is unknown but can be estimated from a sample. the estimation of the survival function can be realised nonparametrically by Kaplan-Meier estimator (12) . An observation is censored if the subject leaves the study or is alive when the study ends. if the data were not censored, the obvious estimate would be the empirical survival function:
where I is the indicator function that takes on the value 1 if the condition in braces is true, and 0 otherwise. the estimator is simply the proportion alive at t. Kaplan and Meier extended the estimate to censored data. the method is described in greater detail by Rodriguez (21) .
Briefly, let 1 2 ... m t t t < < < denote the distinct ordered times of death (not counting censoring times). let d i be the number of deaths at t i , and let n i be the number alive just before t i . this is the number exposed to risk at time t i . the intervals between each time typically will not be uniform. the conditional probability of dying at t i , given that the subject was alive just before, can be estimated by .
When there is no censoring, n i is the number of survivors just prior to time t i ; and when there is censoring, n i is the number of survivors less the number of losses (censored cases), i.e. only the surviving patients that are still being observed ( have not yet been censored) are "at risk" of an (observed) death.
therefore, a Kaplan-Meier survival curve is a step function over time with steps at each time an event occurs, i.e. each failure time. in case of discrete covariates, survival curves for different factor levels can be calculated and compared by log-rank test (sometimes called the Mantel-cox test), which gives an indication of the relevance of the factor, i.e. whether survival in the groups significantly differs (3, 16) . The test was first proposed by Nathan Mantel and was named the "log-rank test" by Peto and Peto (19 
Models derived from the experimental data

Kaplan-Meier method
For estimating the event-free survival rate, the Kaplan-Meier method was used. the time to event (relapse or death) in months was calculated as the time from study entry to first event or data of last contact.
A comparison of the Kaplan-Meier estimators of the survival functions for relapse in the groups of patients without tel-AMl1 and with tel-AMl1 is plotted in Fig. 1 . For the group with tel-AMl1, the results for the Kaplan-Meier estimator are built from the data of relapse in M_event_33 and event_33, and for the group without telAMl1-from the data in M_event_127 and event_127. the conclusions derived from the Kaplan-Meier estimate for the group of patients with tel-AMl1 were the following:
• in the month's interval [0, 48) the probability of relapse is 1.
• in the month's interval [48, 58) the probability decreases and a relapse is possible. For the group of patients without tel-AMl1 the conclusions are:
• the month interval [0, 30) is the most critical of relapse.
• After the 50 th month, the probability for relapse-free time is relatively high (0.68). log-rang test was used for the test of the null hypothesis 
: ( ) ( ) H S t S t
= at the level of significance 0.05
in the comparison of the Kaplan-Meier estimate for the survival function using data for death in the groups of patients without tel-AMl1 and with tel-AMl1 is presented in the following conclusions were derived from the estimate in the group of patients with tel-AMl1:
• the most critical period for lethal outcome is close to the end of the first month.
• the probability for lethal outcome is very low. For the group without tel-AMl1 the conclusions are:
• the month interval [1, 50) is the most critical for death.
• After the 50 th month, the probability for survival is relatively high (0.65).
the same log-rang test was used to test the null hypothesis Table 3 , the first seven rows of the calculation of the test statistics using survival function for death are presented and, as one may see from the bottom of the table, H 0 is rejected because 1 .645 Z > . to describe the effect of other variables, such as age, sex, white blood cell count at diagnosis -leukocytes, risk-type group (Risk-Group), on survival it is convenient to use the hazard function.
The Cox models the proportional hazards model (4) is a simple model to describe the survival between two groups having hazard functions h 1 (t) and h 2 (t). the proportional hazards assumption is that the ratio of these hazard functions does not depend on time:
where ψ is called the proportionality constant (13, 20) . if ψ > 1, the individuals in group 2 have a greater risk of relapsing or dying than the individuals in group 1, regardless of the time t. While ψ does not depend on time, it does depend on the explanatory variables in the model, namely Age, Sex, immunophenotype, leukocytes and type of risk in the group (Risk-Group). A convenient and readily interpretable linear expression for the logarithm of ψ (which can be any real number, since ψ > 1) is obtained:
, where the β's have been subscripted to reflect the role in the hypothesized causal mechanism. The fit of the data to the proportional hazard (cox) regression model for data of relapse is presented in Table 4 . the results of this multivariate proportional hazard regression showed that the variable Sex is not a significant (prognostic) factor for relapse (p = 0.82 > 0.05). the other covariates are statistically significant prognostic factors for the relapse (p < 0.05).
Because the coefficient of Marker is 3 0.86 0 β = > , the individuals with tel-AMl1 could be considered to have a larger log hazards function than those without tel-AMl1. expressed in terms of hR (2) 
Conclusions
the 3-year event-free survival (eFS) varies considerably depending on the risk category, from 95 % (low risk) to 30 % (very high risk), with infant leukemia having the worst outcomes: 20 % for patients younger than 90 days. overall, the cure rate for childhood acute lymphoblastic leukemia (All) is more than 80 %. this study demonstrates the positive significant value of the genetic anomaly TEL-AML1 rearrangement for childhood acute lymphoblastic leukemia (All). the data support that the presence of tel-AMl1 at diagnosis is an independent favorable prognostic indicator in patients with All in Bulgaria.
